Changes in CRP levels (the difference between admission and previous CRP levels) had a better diagnostic value compared to the admission CRP level alone in predicting infection that would prevent chemotherapy in patients with SCLC and in patients with comorbidities. Here, CRP is linked to small cell lung carcinoma.